Post job

AlloVir executives

Here are further demographic highlights of the leadership team:
  • The AlloVir executive team is 42% female and 58% male.
  • 60% of the management team is White.
  • 14% of AlloVir management is Hispanic or Latino.
  • 9% of the management team is Black or African American.
Work at AlloVir?
Share your experience

Rate AlloVir's leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Ann M. Leen

Chief Scientific Officer

Ann M. Leen's LinkedIn

John Wilson

Board Member

John Wilson's LinkedIn

Cliona Rooney

Board Member

Helen Heslop

Founder

Juan F. Vera

Board Member

Juan F. Vera's LinkedIn

Malcolm Brenner

Board Member

Ercem Atillasoy M.D.

Chief Regulatory and Safety Officer

Ercem Atillasoy M.D.'s LinkedIn

Diana M. Brainard

Board Member

Diana M. Brainard's LinkedIn

Edward Miller

General Counsel

Edward Miller's LinkedIn

Jeroen van Beek

Chief Commercial Officer

Jeroen van Beek's LinkedIn

Do you work at AlloVir?

Does the leadership team provide a clear direction for AlloVir?

AlloVir jobs

AlloVir founders

Name & TitleBio
Ann M. Leen

Chief Scientific Officer

Ann M. Leen's LinkedIn

John Wilson

Board Member

John Wilson's LinkedIn

Cliona Rooney

Board Member

Helen Heslop

Founder

Juan F. Vera

Board Member

Juan F. Vera's LinkedIn

Malcolm Brenner

Board Member

AlloVir board members

Name & TitleBio
John Wilson

Board Member

John Wilson's LinkedIn

Cliona Rooney

Board Member

Helen Heslop

Founder

Juan F. Vera

Board Member

Juan F. Vera's LinkedIn

Malcolm Brenner

Board Member

Diana M. Brainard

Board Member

Diana M. Brainard's LinkedIn

Vikas Sinha

Board Member

Vikas Sinha's LinkedIn

Vikas Sinha is the co-founder and chief financial officer of ElevateBio. He used to be the Executive Vice President and Chief Financial Officer for Alexion. In this role, Mr. Sinha has responsibility for global financial management, corporate & strategic development, investor relations, information technology, engineering, and real estate & security activities. Previously, Mr. Sinha spent 11 years with Bayer AG, where he held numerous positions in the United States, Japan, Germany and Canada, including, most recently, the position of Vice President and Chief Financial Officer of Bayer Pharmaceutical Corporation, USA. During his time with Bayer, Mr. Sinha held responsibility for a variety of business functions, including financial and business risk management, strategic planning, contracting, customer services, information systems, and supply chain and site administration in North America. He also served as Vice President and Chief Financial Officer of Bayer Yakuhin Ltd., in Japan, Manager of Mergers and Acquisitions with Bayer AG in Germany, and began his career at Bayer in Toronto in a healthcare executive development program. Prior to Bayer, Mr. Sinha also held several positions of increasing responsibilities with ANZ Bank and Citibank in South Asia. Mr. Sinha holds a master's degree in business administration from the Asian Institute of Management. He is also a qualified Chartered Accountant from the Institute of Chartered Accountants of India.

Jeffrey S. Bornstein

Board Member

Ansbert Gadicke

Board Member

David L. Hallal

Board Member

AlloVir executives FAQs

Zippia gives an in-depth look into the details of AlloVir, including salaries, political affiliations, employee data, and more, in order to inform job seekers about AlloVir. The employee data is based on information from people who have self-reported their past or current employments at AlloVir. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by AlloVir. The data presented on this page does not represent the view of AlloVir and its employees or that of Zippia.

AlloVir may also be known as or be related to ALLOVIR, INC., AlloVir and Allovir, Inc.